Adiposity Patterns and the Risk for ESRD in Postmenopausal Women
Open Access
- 1 February 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 10 (2) , 241-250
Abstract
Background and objectives Body mass index and waist circumference associate with adverse health outcomes, including CKD. Studies of the association of body mass index and ESRD have been inconsistent; these adiposity measures have not been previously assessed together for ESRD risk or among postmenopausal women. Design, settings, participants, & measurements This was prospective cohort study of 20,117 postmenopausal women enrolled in the multiethnic cohort of the Women’s Health Initiative. Body mass index and waist circumference were obtained at baseline, incident ESRD was obtained from the US Renal Data System, and all-cause death was obtained from surveillance data. A competing-risk framework was used to account for the effect of mortality before ESRD while adjusting for significant predictors and baseline kidney function. Associations of adiposity with mortality were also studied. Results Events included 212 patients with incident ESRD and 3104 deaths for a mean follow-up of 11.6 years. Increased waist circumference and body mass index were associated with 2.59- (95% confidence interval, 1.89 to 3.53) and 1.97-fold (95% confidence interval, 1.30 to 2.98) higher hazards of ESRD as well as 1.42- (95% confidence interval, 1.32 to 1.53) and 1.21-fold (95% confidence interval, 1.11 to 1.33) higher hazards of death, respectively, compared with the lower categories in adjusted analyses. The associations of waist circumference with ESRD varied by baseline renal function (P for interaction=0.01) and were significant only among women without baseline eGFR-defined CKD (hazard ratio, 1.93; 95% confidence interval, 1.23 to 3.03). Conclusions Central obesity was associated with an increased risk of ESRD in postmenopausal women, even among women with normal body mass index but not among women with reduced baseline kidney function, and an increased risk of death. Body mass index was associated with ESRD, and the association is likely mediated through hypertension and diabetes.Keywords
This publication has 51 references indexed in Scilit:
- Metabolic Syndrome and Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk PredictionsAmerican Journal of Kidney Diseases, 2010
- Risk Factors for End-Stage Renal DiseaseArchives of internal medicine (1960), 2009
- Association of Multiple Anthropometrics of Overweight and Obesity With Incident Heart FailureCirculation: Heart Failure, 2009
- Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and DeathAmerican Journal of Kidney Diseases, 2008
- Overweight, Obesity, and Elevated Serum Cystatin C Levels in Adults in the United StatesThe American Journal of Medicine, 2008
- Longitudinal Study of Racial and Ethnic Differences in Developing End-Stage Renal Disease among Aged Medicare BeneficiariesJournal of the American Society of Nephrology, 2007
- Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications StudyJournal of the American Society of Nephrology, 2007
- Predictors of New-Onset Kidney Disease in a Community-Based PopulationJAMA, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999